Ronald Zuckermann, director of the Molecular Foundry at Lawrence Berkeley National Laboratory, and his colleagues have created a two-dimensional sugar-coated nanosheet that mimics the surface of cells and, in doing so, can selectively target pathogens like viruses and bacteria.
Light-activated nanoparticles make existing antibiotics more effective against heavily antibiotic-resistant microbes. The research is giving new life to existing drugs that lose their effectiveness against antibiotic-resistant microbes.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Risk of infection continues to be an issue across the healthcare arena. A Frost & Sullivan industry research study published in May 2017 reported that global revenue in the antimicrobial coating materials market stood at $700 million in 2016, and is poised to reach $1.1 billion by 2021.
Sign up for AABME’s white paper series to receive the next white paper authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott.
Researchers seeking to implant a biosensor within the small intestine are developing an implantation capsule robot that can be swallowed.
We are almost ready to share the next AABME white paper, Genome Editing and Biomanufacturing, by Gang Bao, a pioneer in nanomedicine, molecular imaging, and the emerging area of genome editing.
When designed properly, DNA folds into tiny devices that move like macroscopic machines.